EUVIMEDEUVIMED entdecken
Crossref

Optimizing Andrographolide from Sambiloto Leaves ( Andrographis paniculata ) Using Cyclodextrin Metal–Organic Frameworks for Targeted Pulmonary Delivery via a Metered Dose Inhaler: A Proof-Of-Concept Study

Muhammad Ammar Syauqi, Andi Zafirah Burhanuddin, Azzahra Putri Utami Muharam, Ni'mah Azizah, Caesar Putra Gattang, Andi Dian Permana iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.4c00967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Muhammad Ammar Syauqi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Hasanuddin University, Makassar, South Sulawesi 90245, Indonesia. Hauptthemen laut MEDLINE: Cyclodextrins, Diterpenes, Lung, Metal-Organic Frameworks. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Directoral General of Higher Education, Ministry of Education and Culture of Indonesia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

. However, its poor solubility limits its bioavailability. To address this, the creation of an inclusion complex (IC) using cyclodextrin (CD) and Metal-Organic Frameworks (MOFs) offers a promising solution for improving AG's solubility and bioavailability. The AG-CD-MOFs are intended to be delivered via a metered dose inhaler (MDI), allowing for direct targeting of lung tissue. This research focuses on designing AG encapsulated within CD-MOFs to boost solubility and enhance drug efficacy when delivered directly to the lungs via an MDI. Computational molecular modeling indicated that γ-CD is the most suitable host molecule for forming an inclusion complex (IC) with AG, surpassing α-CD and β-CD. The optimal AG to γ-CD ratio for the IC is 1:2 (w/w), with a particle size of 534.53 ± 49.11 nm, a PDI of 0.121 ± 0.01, an encapsulation efficiency (EE) of 89.45 ± 7.03%, and a drug loading (DL) of 26.09 ± 2.87%. The IC exhibits strong antibacterial activity comparable to AG crystal-DMSO, highlighting the importance of solubility in AG's antibacterial efficacy. Additionally, drug release studies revealed that the IC's release profile is nearly nine times greater than that of the AG crystal. In vivo studies further demonstrated the high selectivity of the MDI for lung tissue delivery compared to injection and oral administration, with drug concentrations of 7.44 ± 0.57 μg/mL, 1.52 ± 0.23 μg/mL, and 1.5 ± 0.16 μg/mL, respectively. Moreover, the MDI AG-CD-MOFs exhibited sustained-release properties, maintaining a drug concentration of 5.27 ± 0.75 μg/mL in lung tissue for up to 48 h, significantly higher than injection and oral administration, which only maintained concentrations of 1.52 ± 0.23 μg/mL and 1.50 ± 0.16 μg/mL at 8 h, respectively. The developed formulation shows high selectivity to lung tissue and shows sustained-release behavior. The formula was deemed safe based on in vitro hemolysis and irritation risk tests and did not cause inflammation in lung tissue, as confirmed by histopathology studies. Furthermore, in vivo studies are strongly recommended to validate this therapy and improve pneumonia treatment options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclodextrinsDiterpenesLungMetal-Organic FrameworksAndrographisAnimalsSolubilityPlant LeavesMetered Dose InhalersAnti-Bacterial AgentsBiological AvailabilityProof of Concept StudyDrug Delivery SystemsMiceAdministration, InhalationMale

Stichwörter der Autor:innen

andrographolidecyclodextrinmetal−organic frameworksmetered dose inhalerpneumonia

Substanzen

CyclodextrinsDiterpenesandrographolideMetal-Organic FrameworksAnti-Bacterial Agents

Autor:innen und Institutionen

  • Faculty of Pharmacy, Hasanuddin University, Makassar, South Sulawesi 90245, Indonesia.
  • Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi 90245, Indonesia.

ORCID-Profile: Andi Dian Permana

Förderung

  • Directoral General of Higher Education, Ministry of Education and Culture of Indonesia

Zitieren

APA

Syauqi, M. A., Burhanuddin, A. Z., Muharam, A. P. U., Azizah, N., Gattang, C. P., & Permana, A. D. (2025). Optimizing Andrographolide from Sambiloto Leaves ( Andrographis paniculata ) Using Cyclodextrin Metal–Organic Frameworks for Targeted Pulmonary Delivery via a Metered Dose Inhaler: A Proof-Of-Concept Study. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00967

Vancouver

Syauqi MA, Burhanuddin AZ, Muharam APU, Azizah N, Gattang CP, Permana AD. Optimizing Andrographolide from Sambiloto Leaves ( Andrographis paniculata ) Using Cyclodextrin Metal–Organic Frameworks for Targeted Pulmonary Delivery via a Metered Dose Inhaler: A Proof-Of-Concept Study. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c00967

BibTeX
@article{Syauqi2025,
  author = {Syauqi, Muhammad Ammar and Burhanuddin, Andi Zafirah and Muharam, Azzahra Putri Utami and Azizah, Ni'mah and Gattang, Caesar Putra and Permana, Andi Dian},
  title = {Optimizing Andrographolide from Sambiloto Leaves ( Andrographis paniculata ) Using Cyclodextrin Metal–Organic Frameworks for Targeted Pulmonary Delivery via a Metered Dose Inhaler: A Proof-Of-Concept Study},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.4c00967}
}
Kostenlos starten →